Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
54.7M
-
Shares change
-
+3.27M
-
Total reported value, excl. options
-
$417M
-
Value change
-
+$23.1M
-
Put/Call ratio
-
0.87
-
Number of buys
-
86
-
Number of sells
-
-61
-
Price
-
$7.62
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2022
174 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q1 2022.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.7M shares
of 127M outstanding shares and own 43.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.65M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (8.46M shares), VANGUARD GROUP INC (4.61M shares), STATE STREET CORP (4.42M shares), Soleus Capital Management, L.P. (2.54M shares), Granahan Investment Management, LLC (1.98M shares), Assenagon Asset Management S.A. (1.65M shares), MILLENNIUM MANAGEMENT LLC (1.42M shares), GEODE CAPITAL MANAGEMENT, LLC (1.33M shares), and FEDERATED HERMES, INC. (1.03M shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.